NCT07735234Not yet recruiting
Tolerability of Transcutaneous Vagal Nerve Stimulation
Tolerability of Transcutaneous Auricular Vagus Nerve Stimulation in Pediatric Stroke Survivors 1Tolerability of Transcutaneous Auricular Vagus Nerve Stimulation in Pediatric Stroke Survivors 1
Source: ClinicalTrials.gov · Last updated 29 Jul 2026
Brief summary (registry, in English)
The purpose of this study is to assess the feasibility and tolerability of transcutaneous auricular vagus nerve stimulation (taVNS) in childhood stroke survivors undergoing bi-manual occupational therapy.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 1 (estimated)
- First submitted
- 17 Jul 2026
- Start date
- 30 Jul 2026
- Primary completion date
- 4 Sept 2026
- Lead sponsor
- The University of Texas Health Science Center, Houston
- Diseases
- Stroke
- NCT number
- NCT07735234
What you commit to
- Study type: Interventional
- Planned participants: 1
- From 30 Jul 2026 to the primary completion date, 4 Sept 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Craniectomy without replacement of bone flap. Patients who underwent craniectomy will need the bone flap reattached prior to participation.
- Presence of cranial metal implants or implant device that could be affected by taVNS: cochlear implant, implanted brain stimulator, or programmable ventriculoperitoneal shunt.
Who the study is looking for
- Childhood stroke survivor - either arterial ischemic stroke or intracerebral hemorrhage.
- Stroke must be childhood onset, defined as occurring day 29 of life to 18 years of age (per the American Heart Association's definition of childhood stroke)
- 6 months or greater from stroke onset
- Arm impairment, defined as pediatric stroke outcome measure of 1 or greater of affected arm.
- Affected arm Fugl-Meyer score of 60 or lower.
- Able to participate in occupational therapy sessions.
Age in the registry: 13 years to 21 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| The University of Texas Health Science Center at Houston Coordinator of this site? Confirm its status | Houston | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.